Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2016

Feb 25, 2016

30643_dirs_2016-02-25_5f8e94c5-1582-4c2e-8786-135afd35b1ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-02-23

Reporting Person: ZUMWALT LEANNE M (Grp VP, Purch & Public Affairs)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-23 Common Stock M 44000 $43.35 Acquired 53068 Direct
2016-02-23 Common Stock F 29413 $64.85 Disposed 23655 Direct
2016-02-23 Common Stock S 14587 $64.2535 Disposed 9068 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-23 Stock Appreciation Rights $43.35 M 44000 Disposed 2016-04-13 Common Stock (44000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 807 Indirect

Footnotes

F1: Includes 64 shares acquired under Issuer's employee stock purchase plan on 12/31/2015 and 94 shares acquired through Issuer's 401(k) Retirement Plan.

F2: Represents the weighted average sale price of $64.2535. The range of prices for the sale of these shares was $64.25-$64.31 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: The Stock Appreciation Rights were granted on 4/13/2011; 50% vested on 4/13/2014, and the remaining 50% vested on 4/13/2015.